Human immunodeficiency virus type 1 entry inhibitors PRO 542 and T-20 are potently synergistic in blocking virus-cell and cell-cell fusion.
Nagashima, K A
Human immunodeficiency virus type 1 entry inhibitors PRO 542 and T-20 are potently synergistic in blocking virus-cell and cell-cell fusion. [electronic resource] - The Journal of infectious diseases Apr 2001 - 1121-5 p. digital
Publication Type: Comparative Study; Journal Article; Research Support, U.S. Gov't, P.H.S.
0022-1899
10.1086/319284 doi
Animals
Anti-HIV Agents--pharmacology
CD4 Immunoadhesins--pharmacology
CHO Cells
Cell Fusion
Cell Line
Cricetinae
Dose-Response Relationship, Drug
Drug Synergism
Enfuvirtide
Eukaryotic Cells--pathology
HIV Envelope Protein gp41--pharmacology
HIV Infections--virology
HIV-1--drug effects
HeLa Cells
Humans
Peptide Fragments--pharmacology
T-Lymphocytes--virology
Virus Replication--drug effects
Human immunodeficiency virus type 1 entry inhibitors PRO 542 and T-20 are potently synergistic in blocking virus-cell and cell-cell fusion. [electronic resource] - The Journal of infectious diseases Apr 2001 - 1121-5 p. digital
Publication Type: Comparative Study; Journal Article; Research Support, U.S. Gov't, P.H.S.
0022-1899
10.1086/319284 doi
Animals
Anti-HIV Agents--pharmacology
CD4 Immunoadhesins--pharmacology
CHO Cells
Cell Fusion
Cell Line
Cricetinae
Dose-Response Relationship, Drug
Drug Synergism
Enfuvirtide
Eukaryotic Cells--pathology
HIV Envelope Protein gp41--pharmacology
HIV Infections--virology
HIV-1--drug effects
HeLa Cells
Humans
Peptide Fragments--pharmacology
T-Lymphocytes--virology
Virus Replication--drug effects